Security key
69353Y103
PMV Pharmaceuticals, Inc. - Common stock, par value $0.00001 (PMVP)
CUSIP: 69353Y103
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common stock, par value $0.00001
- Total 13F shares
- 37,492,718
- Total 13F value
- $52,488,395
- Share change
- +2,812,009
- SEC-reported price per share
- $1.40
- Number of holders
- 63
- Value change
- +$4,772,987
- Number of buys
- 31
- Number of sells
- 27
- Shares outstanding
- 53,394,523
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
63
Top holders
10
PMVP full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Previous quarter: Q2 2025
PMV Pharmaceuticals, Inc. SEC filings
PMV Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 69353Y103
Recent filing periods:
Ownership snapshot
Top reported holders of PMVP - PMV Pharmaceuticals, Inc. - Common stock, par value $0.00001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
TANG CAPITAL MANAGEMENT LLC
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
15/15
Latest evidence
16 Sep 2025
13D/G
13F
3/4/5
Lead comparable stake: 8.9%
13D/G row: TANG CAPITAL MANAGEMENT LLC
Showing 1-6 of 15 holder rows.
Quick read
TANG CAPITAL MANAGEMENT LLC leads the comparable SEC ownership view at 8.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens TANG CAPITAL MANAGEMENT LLC's linked filing trail.
Comparable ownership
Top 5
TANG CAPITAL MANAGEMENT LLC
8.9%
ORBIMED ADVISORS LLC
12%
BML Capital Management, LLC
9.4%
Sio Capital Management, LLC
7%
ArrowMark Colorado Holdings LLC
6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC |
13D/G
|
8.9%
|
$6,702,907
4,720,357 shares
|
$0 | 16 Sep 2025 |
| ORBIMED ADVISORS LLC |
13F
Company
|
12%
|
$6,863,808
6,475,291 shares
|
— | 30 Jun 2025 |
| BML Capital Management, LLC |
13F
Company
|
9.4%
|
$5,300,000
5,000,000 shares
|
— | 30 Jun 2025 |
| Sio Capital Management, LLC |
13F
Company
|
7%
|
$3,959,520
3,735,396 shares
|
— | 30 Jun 2025 |
| ArrowMark Colorado Holdings LLC |
13F
Company
|
6%
|
$3,379,403
3,188,116 shares
|
— | 30 Jun 2025 |
| Euclidean Capital LLC |
13F
3/4/5
Company · 10%+ Owner
|
4.9%
|
$2,785,302
2,627,643 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
63
Shares
37,492,718
Rows available
63
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
52
Q3 2025 holders
63
Holder diff
11
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend